These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7993073)

  • 21. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum.
    Kashman Y; Gustafson KR; Fuller RW; Cardellina JH; McMahon JB; Currens MJ; Buckheit RW; Hughes SH; Cragg GM; Boyd MR
    J Med Chem; 1992 Jul; 35(15):2735-43. PubMed ID: 1379639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imidazo[1,5-b]pyridazine-d4T conjugates: synthesis and anti-human immunodeficiency virus evaluation.
    Renoud-Grappin M; Fossey C; Fontaine G; Ladurée D; Aubertin AM; Kirn A
    Antivir Chem Chemother; 1998 May; 9(3):205-23. PubMed ID: 9875400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587.
    Koup RA; Merluzzi VJ; Hargrave KD; Adams J; Grozinger K; Eckner RJ; Sullivan JL
    J Infect Dis; 1991 May; 163(5):966-70. PubMed ID: 1708400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents.
    Barreca ML; Chimirri A; De Luca L; Monforte AM; Monforte P; Rao A; Zappalà M; Balzarini J; De Clercq E; Pannecouque C; Witvrouw M
    Bioorg Med Chem Lett; 2001 Jul; 11(13):1793-6. PubMed ID: 11425562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
    Ahgren C; Backro K; Bell FW; Cantrell AS; Clemens M; Colacino JM; Deeter JB; Engelhardt JA; Hogberg M; Jaskunas SR
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1329-35. PubMed ID: 7574525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.
    Garvey EP; Johns BA; Gartland MJ; Foster SA; Miller WH; Ferris RG; Hazen RJ; Underwood MR; Boros EE; Thompson JB; Weatherhead JG; Koble CS; Allen SH; Schaller LT; Sherrill RG; Yoshinaga T; Kobayashi M; Wakasa-Morimoto C; Miki S; Nakahara K; Noshi T; Sato A; Fujiwara T
    Antimicrob Agents Chemother; 2008 Mar; 52(3):901-8. PubMed ID: 18160521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and anti-HIV-1 activity of a series of imidazo[1,5-b]pyridazines.
    Livermore DG; Bethell RC; Cammack N; Hancock AP; Hann MM; Green DV; Lamont RB; Noble SA; Orr DC; Payne JJ
    J Med Chem; 1993 Nov; 36(24):3784-94. PubMed ID: 7504733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potent and specific inhibition of human immunodeficiency virus type 1 replication by 4-(2,6-dichlorophenyl)-1,2,5-thiadiazol-3-Y1 N,N-dialkylcarbamate derivatives.
    Ijichi K; Fujiwara M; Hanasaki Y; Watanabe H; Katsuura K; Takayama H; Shirakawa S; Sakai S; Shigeta S; Konno K
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2337-40. PubMed ID: 8619592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
    Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
    J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-aminoimidazole derivatives inhibiting retroviral replication via a yet unidentified mode of action.
    Lagoja IM; Pannecouque C; Van Aerschot A; Witvrouw M; Debyser Z; Balzarini J; Herdewijn P; De Clercq E
    J Med Chem; 2003 Apr; 46(8):1546-53. PubMed ID: 12672256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase.
    Pauwels R; Andries K; Debyser Z; Van Daele P; Schols D; Stoffels P; De Vreese K; Woestenborghs R; Vandamme AM; Janssen CG
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1711-5. PubMed ID: 7680476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication.
    Balzarini J; Pelemans H; Aquaro S; Perno CF; Witvrouw M; Schols D; De Clercq E; Karlsson A
    Mol Pharmacol; 1996 Aug; 50(2):394-401. PubMed ID: 8700148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bicyclic nucleoside inhibitors of varicella-zoster virus modified on the sugar moiety: 3' and 5' derivatives.
    Luoni GM; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
    Antivir Chem Chemother; 2004 Nov; 15(6):333-41. PubMed ID: 15646647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.
    De Clercq E; Yamamoto N; Pauwels R; Baba M; Schols D; Nakashima H; Balzarini J; Debyser Z; Murrer BA; Schwartz D
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5286-90. PubMed ID: 1608936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Favorable interaction of beta-L(-) nucleoside analogues with clinically approved anti-HIV nucleoside analogues for the treatment of human immunodeficiency virus.
    Bridges EG; Dutschman GE; Gullen EA; Cheng YC
    Biochem Pharmacol; 1996 Mar; 51(6):731-6. PubMed ID: 8602867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro inhibition of human immunodeficiency virus type 1 by a combination of delavirdine (U-90152) with protease inhibitor U-75875 or interferon-alpha.
    Pagano PJ; Chong KT
    J Infect Dis; 1995 Jan; 171(1):61-7. PubMed ID: 7528253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs.
    Witvrouw M; De Clercq E
    Gen Pharmacol; 1997 Oct; 29(4):497-511. PubMed ID: 9352294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thiazolobenzimidazole: biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor.
    Buckheit RW; Hollingshead MG; Germany-Decker J; White EL; McMahon JB; Allen LB; Ross LJ; Decker WD; Westbrook L; Shannon WM
    Antiviral Res; 1993 Jul; 21(3):247-65. PubMed ID: 7692815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and anti-HIV activity of 1,1,3-trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazines (TTDs): a new family of HIV-1 specific non-nucleoside reverse transcriptase inhibitors.
    Arranz ME; Díaz JA; Ingate ST; Witvrouw M; Pannecouque C; Balzarini J; De Clercq E; Vega S
    Bioorg Med Chem; 1999 Dec; 7(12):2811-22. PubMed ID: 10658585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitor.
    McMahon JB; Buckheit RW; Gulakowski RJ; Currens MJ; Vistica DT; Shoemaker RH; Stinson SF; Russell JD; Bader JP; Narayanan VL; Schultz RJ; Brouwer WG; Felauer EE; Boyd MR
    J Pharmacol Exp Ther; 1996 Jan; 276(1):298-305. PubMed ID: 8558446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.